{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:34:44Z","timestamp":1783524884121,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T00:00:00Z","timestamp":1590624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.05.076","type":"journal-article","created":{"date-parts":[[2020,6,19]],"date-time":"2020-06-19T07:43:09Z","timestamp":1592552589000},"page":"5286-5296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization"],"prefix":"10.1016","volume":"38","author":[{"given":"Nayara Fernanda Barros","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas Raposo","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fagner James Martins Dantas","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniely Maranh\u00e3o","family":"de Mattos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"En\u00e9as","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds Carlos de Souza","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita de C\u00e1ssia Caf\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.076_b0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2051013615579869","article-title":"Group B Streptococcus vaccine: state of the art","volume":"3","author":"Nuccitelli","year":"2015","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.vaccine.2020.05.076_b0010","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.bpobgyn.2007.01.003","article-title":"Perinatal group B streptococcal disease","volume":"21","author":"Heath","year":"2007","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0140-6736(11)61651-6","article-title":"Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis","volume":"379","author":"Edmond","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.05.076_b0020","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.00117-07","article-title":"Serotype IX, a Proposed New Streptococcus agalactiae Serotype","volume":"45","author":"Slotved","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12864-017-3820-5","article-title":"Comparison of molecular serotyping approaches of Streptococcus agalactiae from genomic sequences","volume":"18","author":"Kapatai","year":"2017","journal-title":"BMC Genomics"},{"key":"10.1016\/j.vaccine.2020.05.076_b0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1086\/599369","article-title":"Increasing burden of invasive Group B Streptococcal disease in nonpregnant adults, 1990\u20132007","volume":"49","author":"Skoff","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.076_b0035","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/JCM.00421-08","article-title":"Molecular characterization of human-colonizing Streptococcus agalactiae strains isolated from throat, skin, anal margin, and genital body sites","volume":"46","author":"van der Mee-Marquet","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0040","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10930-011-9317-1","article-title":"Expression, purification and structural analysis of a fibrinogen receptor FbsA from Streptococcus agalactiae","volume":"30","author":"Ragunathan","year":"2011","journal-title":"Protein J"},{"key":"10.1016\/j.vaccine.2020.05.076_b0045","doi-asserted-by":"crossref","first-page":"D3","DOI":"10.1016\/j.vaccine.2013.02.030","article-title":"The spectrum of perinatal group B streptococcal disease","volume":"31","author":"Baker","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0050","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/infdis\/148.5.802","article-title":"Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures","volume":"148","author":"Boyer","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.076_b0055","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1093\/cid\/cix658","article-title":"Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.076_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00505","article-title":"Increased risk of Group B Streptococcus invasive infection in HIV-exposed but uninfected infants: a review of the evidence and possible mechanisms","volume":"7","author":"Dauby","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2017.01497","article-title":"Codevelopment of microbiota and innate immunity and the risk for group B streptococcal disease","volume":"8","author":"Kolter","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0070","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM198606263142603","article-title":"Prevention of early-onset neonatal Group B Streptococcal disease with selective intrapartum chemoprophylaxis","volume":"314","author":"Boyer","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.05.076_b0075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1473-3099(03)00577-2","article-title":"Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis","volume":"3","author":"Moore","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.076_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/INF.0b013e3181b83cd9","article-title":"Group B Streptococcus early-onset disease in Emilia-Romagna: review after introduction of a screening-based approach","volume":"29","author":"Berardi","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.05.076_b0085","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1056\/NEJM198811033191802","article-title":"Immunization of pregnant women with a polysaccharide vaccine of group B Streptococcus","volume":"319","author":"Baker","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.05.076_b0090","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1128\/IAI.69.11.6696-6701.2001","article-title":"Effects of alum adjuvant or a booster dose on immunogenicity during clinical trials of group B Streptococcal Type III conjugate vaccines","volume":"69","author":"Paoletti","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0095","doi-asserted-by":"crossref","unstructured":"Chen VL, Avci FY, Kasper DL. A maternal vaccine against group B Streptococcus: Past, present, and future. Vaccine 2013;31:D13\u2013D19. https:\/\/doi.org\/10.1016\/j.vaccine.2012.12.080.","DOI":"10.1016\/j.vaccine.2012.12.080"},{"key":"10.1016\/j.vaccine.2020.05.076_b0100","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrmicro1552","article-title":"Group B Streptococcus: global incidence and vaccine development","volume":"4","author":"Johri","year":"2006","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0105","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1128\/IAI.70.6.2869-2876.2002","article-title":"Identification of novel adhesins from Group B streptococci by use of phage display reveals that C5a peptidase mediates fibronectin binding","volume":"70","author":"Beckmann","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0110","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1128\/IAI.70.5.2408-2413.2002","article-title":"The Group B Streptococcal C5a peptidase is both a specific protease and an invasin","volume":"70","author":"Cheng","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0115","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1128\/IAI.72.2.1184-1187.2004","article-title":"Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection","volume":"72","author":"Larsson","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0120","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/iai.64.9.3518-3523.1996","article-title":"Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha","volume":"64","author":"Larsson","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0125","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","article-title":"Status of vaccine research and development of vaccines for GBS","volume":"34","author":"Heath","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0130","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/603540","article-title":"BibA induces opsonizing antibodies conferring in vivo protection against Group B Streptococcus","volume":"200","author":"Santi","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.05.076_b0135","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1016\/j.vaccine.2011.09.010","article-title":"Exploiting mucosal surfaces for the development of mucosal vaccines","volume":"29","author":"Meeusen","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0140","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jconrel.2016.05.001","article-title":"A novel adjuvanted capsule based strategy for oral vaccination against infectious diarrhoeal pathogens","volume":"233","author":"Davitt","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2020.05.076_b0145","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.vaccine.2009.01.083","article-title":"Alpha-galactosylceramide is an effective mucosal adjuvant for repeated intranasal or oral delivery of HIV peptide antigens","volume":"27","author":"Courtney","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0150","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.vaccine.2010.11.091","article-title":"Non-toxic derivatives of LT as potent adjuvants","volume":"29","author":"da Hora","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0155","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1084\/jem.180.6.2147","article-title":"A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit","volume":"180","author":"Pizza","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.05.076_b0160","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.4049\/jimmunol.179.8.5346","article-title":"The acquired immune response to the mucosal adjuvant LTK63 imprints the mouse lung with a protective signature","volume":"179","author":"Tritto","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0165","doi-asserted-by":"crossref","first-page":"D52","DOI":"10.1016\/j.vaccine.2013.02.029","article-title":"Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants","volume":"31","author":"Madhi","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0170","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1128\/JB.00370-09","article-title":"CsrRS regulates Group B Streptococcus Virulence gene expression in response to environmental pH: a new perspective on vaccine development","volume":"191","author":"Santi","year":"2009","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0175","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2958.2006.05555.x","article-title":"BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood","volume":"63","author":"Santi","year":"2007","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0180","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.mimet.2009.11.010","article-title":"A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae","volume":"80","author":"Imperi","year":"2010","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2020.05.076_b0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1128\/jcm.16.1.141-144.1982","article-title":"Whole-bacterial cell enzyme-linked immunosorbent assay for Streptococcus sanguis fimbrial antigens","volume":"16","author":"Elder","year":"1982","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0190","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4161\/hv.4.5.5988","article-title":"Functional activity of antisera to group B streptococcal conjugate vaccines measured with an opsonophagocytosis assay and HL-60 effector cells","volume":"4","author":"Guttormsen","year":"2008","journal-title":"Hum Vaccin"},{"key":"10.1016\/j.vaccine.2020.05.076_b0195","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1128\/IAI.68.10.5610-5618.2000","article-title":"Identification of group B streptococcal Sip protein, which elicits cross-protective immunity","volume":"68","author":"Brodeur","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0200","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1574-695X.2009.00623.x","article-title":"Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice","volume":"58","author":"Xue","year":"2010","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0205","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.vaccine.2017.01.029","article-title":"Mucosal vaccination promotes clearance of Streptococcus agalactiae vaginal colonization","volume":"35","author":"Baker","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.05.076_b0210","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196564","article-title":"Development of experimental GBS vaccine for mucosal immunization","volume":"13","author":"Gupalova","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.05.076_b0220","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.05.076_b0225","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4161\/hv.19568","article-title":"The mucosal vaccine quandary: Intranasal vs. sublingual immunization against influenza","volume":"8","author":"Pedersen","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.05.076_b0230","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1128\/IAI.71.12.6915-6920.2003","article-title":"Th1-Directing adjuvants increase the immunogenicity of oligosaccharide-protein conjugate vaccines related to Streptococcus pneumoniae Type 3","volume":"71","author":"Lefeber","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.076_b0235","doi-asserted-by":"crossref","first-page":"17281","DOI":"10.1038\/srep17281","article-title":"Streptococcus agalactiae serotype distribution and antimicrobial susceptibility in pregnant women in Gabon, Central Africa","volume":"5","author":"Belard","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.05.076_b0240","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/mi.2015.23","article-title":"Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus","volume":"8","author":"Patras","year":"2015","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2020.05.076_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.00437","article-title":"Group B Streptococcal colonization, molecular characteristics, and epidemiology","volume":"9","author":"Shabayek","year":"2018","journal-title":"Front Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20307313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:51Z","timestamp":1759401951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20307313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":49,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20307313"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with a recombinant BibA surface protein confers immunity and protects mice against group B Streptococcus (GBS) vaginal colonization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}